EXACT SCIENCES CORP 4

Director Michael J. Barber surrendered 7,738 shares of Exact Sciences common stock and 7,422 deferred stock units for cash at $105.00 per share in connection with the Abbott Laboratories merger.

On March 23, 2026, director Michael J. Barber’s equity in Exact Sciences Corp. was cashed out in connection with the closing of the Abbott Laboratories acquisition. All 7,738 shares of common stock held directly were disposed of for cash at the $105.00 per share merger consideration, resulting in proceeds of approximately $812,490 and reducing his direct common stock ownership to 5,398 shares prior to their own cancellation under the merger. In addition, 7,422 deferred stock units, granted under the company’s non‑employee director compensation policy and each convertible into one share of common stock, were fully vested and cancelled at the effective time of the merger, with each DSU converted into the right to receive $105.00 in cash (about $779,310 in aggregate), leaving Barber with no remaining DSU or common stock holdings in the issuer following the transaction.

Filing Facts

CIK

1124140

Ticker

EXAS

Form

4

Source Type

sec

Accession

0001193125-26-118742

Alert Tier

6